Clinical trial
ACT Lung Health Intervention: Phase Two
NCT06945120
Study timeline
Study start (actual)2025-11-04Date precision: day
Registry last updated2026-03-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Smoking Cessationunresolved
Smoking Behaviorsunresolved
Smoking, Tobaccounresolved
Smoking, Cigaretteunresolved
Smoking (Tobacco) Addictionunresolved
Interventions
ACT Lung Health InterventionBEHAVIORAL
Sponsors & collaborators
Dana-Farber Cancer Institutelead sponsor
National Cancer Institute (NCI)collaborator
University of Massachusetts, Bostoncollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06945120 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.